Form 4: Labcorp Director Kerrii B. Anderson Reports Stock Sales

Director Kerrii B. Anderson reported the sale of Labcorp Holdings Inc. (LH) common stock on August 7th and 8th, 2024, according to a Form 4 filing with the SEC.

Summary

• Kerrii B. Anderson, a director of Labcorp Holdings Inc. (LH), filed a Form 4 with the SEC.
• The filing reports the sale of common stock on August 7, 2024, and August 8, 2024.
• On August 7, 2024, 414 shares were sold at $225 per share.
• On August 8, 2024, 586 shares were sold at $225 per share.
• Following these transactions, Anderson directly owns 14,722 shares of Labcorp common stock.
• Anderson also indirectly owns 144 shares through the Alexa M. Anderson Separate Trust and 144 shares through the Cameron Taff Anderson Separate Trust.
• The sales were made pursuant to a pre-arranged trading plan under Rule 10b5-1.
• Labcorp Holdings Inc. (LHI) became the successor of Laboratory Corporation of America Holdings (LCAH) on May 17, 2024, due to a reorganization.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document simply reports stock sales by a director, which could be for various reasons and doesn't necessarily indicate a negative outlook on the company.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Comparison to Industry Standards

• Comparing insider trading activity to peers such as Quest Diagnostics (DGX) or Charles River Laboratories (CRL) can provide context.
• Monitoring the frequency and size of insider transactions relative to these companies can offer insights into market sentiment.
• However, without additional context, it's difficult to determine if these sales are indicative of a broader trend or simply personal financial planning.

Stakeholder Impact

• The stock sales by a director could potentially influence investor sentiment, although the impact is likely to be minimal given the relatively small number of shares sold.
• The sales were executed under a pre-arranged trading plan, which may reassure investors that the transactions were not based on insider information.

Key Dates